Breaking News, Promotions & Moves

Evox Therapeutics Taps Dr. Per Lundin as CEO

Lundin has 15+ years’ experience founding, leading and advising biotech companies, including co-founding Evox in 2016.

Author Image

By: Charlie Sternberg

Associate Editor

Evox Therapeutics Ltd, an exosome therapeutics company, has appointed Dr. Per Lundin, Co-Founder and Chief Business Officer, as Chief Executive Officer (CEO) of the Company and a member of its Board of Directors.   Following more than six years with the Company, Dr. Antonin “Tony” de Fougerolles has decided to step down as CEO and Director of Evox. Tony will continue to support the Company as a strategic adviser. About Dr. Per Lundin Lundin has more than 15 years’ experience founding, lea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters